Sarepta Therapeutics (SRPT) Share-based Compensation (2010 - 2026)
Sarepta Therapeutics' Share-based Compensation was $24.47 million in Q2 2026, down 33.9% from $37.03 million a year earlier and down 16.8% from the prior quarter.
Powered by 
Analysis
Sarepta Therapeutics (SRPT) Share-based Compensation (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Sarepta Therapeutics' Share-based Compensation was $98.81 million through Jun 30, 2026, down 42.4% year-over-year; for FY2025, it came in at $123.4 million, down 33.0% from FY2024.
- Share-based Compensation shows a five-year compound annual growth rate of 2.7% (FY2020 to FY2025).
- In earlier years, Share-based Compensation was $184.3 million in FY2024 (+1.0%), $182.51 million in FY2023 (-21.7%), $233.02 million in FY2022 (+104.5%) and $113.94 million in FY2021 (+5.4%).
- Quarterly Share-based Compensation has moved between $10.3 million (Q3 2023) and $102.89 million (Q2 2022) over five years.
- Compared with a year earlier, Share-based Compensation has declined for five straight quarters, with growth averaging 17.2% over the last eight quarters.
- The best year-over-year quarter for Share-based Compensation over five years was Q3 2024 (growth of 321.8%); the worst was Q3 2023 (a decline of 79.6%).
- Per Business Quant data, SRPT's Share-based Compensation in the three quarters before Q2 2026 was $29.4 million (Q1 2026), $30.02 million (Q4 2025) and $14.93 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Sarepta Therapeutics | 1.96 Bn | -1.27 Bn | 251.87 Mn | 28.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28.03 Mn |
| Mar 31, 2026 | 33.67 Mn |
| Dec 31, 2025 | 45.68 Mn |
| Sep 30, 2025 | 16.40 Mn |
| Jun 30, 2025 | 41.62 Mn |
| Mar 31, 2025 | 46.56 Mn |
| Dec 31, 2024 | 70.51 Mn |
| Sep 30, 2024 | 49.00 Mn |
| Jun 30, 2024 | 55.65 Mn |
| Mar 31, 2024 | 45.21 Mn |
| Dec 31, 2023 | 45.81 Mn |
| Sep 30, 2023 | 48.10 Mn |
| Jun 30, 2023 | 47.38 Mn |
| Mar 31, 2023 | 41.25 Mn |
| Dec 31, 2022 | 50.51 Mn |
| Sep 30, 2022 | 50.42 Mn |
| Jun 30, 2022 | 102.89 Mn |
| Mar 31, 2022 | 29.20 Mn |
| Dec 31, 2021 | 29.74 Mn |
| Sep 30, 2021 | 26.70 Mn |
API Access
Sarepta Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=SRPT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "SRPT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=SRPT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();